Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
02/2005
02/16/2005EP1506157A2 Amino-functional chalcones
02/16/2005EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
02/16/2005EP1505962A2 Monotherapy for the treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
02/16/2005EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors
02/16/2005EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity
02/16/2005EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient
02/16/2005EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers
02/16/2005CN1582282A Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
02/16/2005CN1582154A Method for treating or prophylaxis of aldo sterone-medicated phthogenic effects in subjwect using epoxy-steroidal aldosterone antagonist
02/16/2005CN1580050A Method for preparing phthalic anhydride
02/16/2005CN1580049A Method for extracting total phenyl phthalein of ligusitcum wallichii
02/16/2005CN1580043A Anti malignant tumour southern radix bupleuri extract preparing method
02/16/2005CN1189463C Method for preparing monochlorophthalic anhydride by chloration of phthalic anhydride
02/15/2005US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders
02/15/2005US6855842 Nitrating a 2-(2-formylphenoxy) or 2-(2-formylphenylsulfido) alkyl ester or alkoic acid in the presence of sulfuric acid
02/15/2005US6855835 Allomorph of isomer Z hydrochloride of alkylaminofurane derivative
02/15/2005US6855834 By cyanide exchange reaction of the corresponding halo- or perfluoroalkylsulfonyl substituted citalopram derivative, film distillation
02/15/2005US6855831 Converting substituted mono or bicyclic lactones in presence of an amine base and a catalytic amount of a cyanide or alkali or alkaline metal alcoholate, to a salt, reacting the salt with carbonyl compound containing an organic substituent
02/15/2005US6855822 Benzo[b]furan dimers
02/10/2005WO2005012280A1 Alkynyl aryl carboxamides
02/10/2005WO2005012278A2 Process for purifying citalopram using polybasic acids
02/10/2005WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor
02/10/2005WO2005011670A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
02/10/2005US20050033100 Diels-Alder reaction; using zeolite y in exchanged with copper; separated from mixture for reuse
02/10/2005US20050033081 Treating an animal for parasites
02/10/2005US20050033076 Coordination polymerization catalysts
02/10/2005US20050033067 cis-fused tetracyclic alcohol intermediates, the methanamine end-products, the methanamine end-products for use as a medicine, in particular as CNS active medicines
02/10/2005US20050032887 Novel lactone compound
02/10/2005US20050032886 Use of parthenolide derivatives as antileukemic and cytotoxic agents
02/10/2005US20050032885 Use as pesticides, microbicides and herbicides; compatible with crop plants
02/10/2005US20050032860 CBI analogs of CC-1065 and the duocarmycins
02/10/2005US20050032851 E. g.,N-[[4-[2-(5-Methylpyridin-3-yl)-4-(trifluoromethyl)-1H-imidazol-1-yl]phenyl]sulfonyl]acetamide; side effect reduction; non-steroidal antiinflammatory agents; antiarthritic agents; analgesics; antipyretics; acylation of the corresponding sulfoamide by an anhydride a solvent and base
02/10/2005US20050032820 Novel spiro compounds
02/10/2005US20050032805 Antimicrobial biaryl compounds
02/10/2005US20050032796 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis
02/10/2005US20050032794 For example, 2-Dimethylamino-N-(3-dimethylamino-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-N-methyl-acetamide; ability to function as gene expression modulators for genes found in cancer cells, especially genes involved in misregulated signal transduction pathways typical of cancers of colon and breast
02/10/2005US20050029705 Extrusion die
02/10/2005CA2534127A1 Substituted benzothiophene compounds and uses thereof
02/10/2005CA2527861A1 Alkynyl aryl carboxamides
02/09/2005EP1503999A1 Dihydroxyhexanoic acid derivatives, their intermediates, and methods of making
02/09/2005EP1503981A2 Substituted tetracycline compounds
02/09/2005EP1503761A1 Substituted piperazines as melanocortin receptor ligands
02/09/2005EP1503750A1 Method for the preparation of matairesinol
02/09/2005EP1487795A4 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
02/09/2005EP1349846B1 Arylated furane and thiophene carboxylic acid amides with potassium channel blocking effect
02/09/2005EP1294705A4 Synthesis of cyclic compounds
02/09/2005EP1274980A4 Solution and crystal structures of mmp-13 active site and uses thereof
02/09/2005EP1150960B1 Polymorphic crystalline forms of celecoxib
02/09/2005EP1124443B1 Solid delivery systems for aroma ingredients
02/09/2005CN1578763A Selective herbicides based on substituted arylsulfonylaminocarbonyl triazolinones and safeners
02/09/2005CN1578663A Inhibitors of histone deacetylase
02/09/2005CN1578659A Modulators of peroxisome proliferator activated receptors (ppar)
02/09/2005CN1575816A Compounds for the treatment of female sexual dysfunction
02/09/2005CN1188420C Fungicides for preventing and curing full rot disease of plants
02/09/2005CN1188419C Fungicides for control of full-rot disease of plants
02/09/2005CN1188378C Process for co-production of aliphatic 1. 4 dihydric alcohol and oxolane
02/08/2005US6852868 Catalytic hydrogenation of furfural to produce 2-methylfuran and 2-methyltetrahydrofuran, using a reduced copper based catalyst containing oxides of copper in cupric form, chromiumIII, manganese, and barium and a reduced nickel II
02/08/2005US6852867 Preparing 5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran by formylating 4-acyloxy-3,5-di-tert-butylphenol; alkylating with a metal hydride and a 6-undecylmagnesium halide, cyclizing and deprotecting
02/08/2005US6852865 Epoxides, aziridines, thiiranes, oxetanes, lactones, lactams and analogous compounds are reacted with carbon monoxide in the presence of a catalytically effective amount of catalyst complex of transition metal carbonyl and Lewis acid
02/08/2005US6852754 Treatment of cancer and cell proliferation
02/08/2005US6852751 Difluorobutyric acid metalloprotease inhibitors
02/08/2005US6852750 Spinal cord injury, demyelinating diseases, Parkinson's disease, Amyotrophic Lateral Sclerosis, alcohol, nicotine, cocaine dependence, neuropathy, pain and schizophrenia; antiischemic, - carcinogenic agents; NAALADase inhibitors
02/08/2005US6852711 HIV protease inhibitors
02/08/2005US6852350 For flavouring of foodstuffs
02/08/2005CA2096525C Retroviral protease inhibitors
02/08/2005CA2096409C Retroviral protease inhibitors
02/08/2005CA2096408C Retroviral protease inhibitors
02/03/2005WO2005009993A1 Novel compounds
02/03/2005WO2005009941A1 Indane derivates as muscarinic receptor agonists
02/03/2005WO2005009940A1 Novel aminobenzophenone compounds
02/03/2005WO2004100998A3 Compositions and methods for non-invasive imaging of soluble beta-amyloid
02/03/2005WO2004094369A3 Stabilized derivatives of ascorbic acid
02/03/2005WO2004074242A3 Halogenated oxime derivatives and the use thereof as latent acids
02/03/2005WO2004069774A3 Synthesis of 13c-labelled estrogen analogues
02/03/2005US20050027129 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
02/03/2005US20050027120 Method for the synthesis of amides and related products from esters or ester-like compounds
02/03/2005US20050026969 Heterocyclic compounds useful as malonyl-CoA decarboxylase inhibitors
02/03/2005US20050026968 Heterocyclic amides with anti-tuberculosis activity
02/03/2005US20050026904 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
02/03/2005US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke
02/03/2005US20050026874 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility
02/03/2005US20050026785 Novel phenyl-propargylether derivatives
02/03/2005US20050025997 Luminescent layer between electrodes
02/03/2005US20050023507 pi-electron donor group bonded to a pi-electron conjugated bridge group bonded to a mono- or dicyanodihydrofuran acceptor; large hyperpolarizability, dipole moment, and electrooptic coefficients; electrooptics
02/03/2005CA2744317A1 Substituted tetracycline compounds
02/03/2005CA2532248A1 Novel compounds
02/03/2005CA2530302A1 Novel aminobenzophenone compounds
02/03/2005CA2529036A1 Indane derivates as muscarinic receptor agonists
02/02/2005EP1502576A2 Composition containing a 2-thioacetamide and use thereof for stimulating growth or preventing fall out of keratin fibres
02/02/2005EP1501841A2 Non nucleoside reverse transcriptase inhibitors
02/02/2005EP1501816A1 Method for producing gamma-butyrolactone
02/02/2005EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators
02/02/2005EP1501791A1 Amino acid analogues
02/02/2005EP1286955B1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
02/02/2005EP1165534B1 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
02/02/2005CN1575283A Piperazine derivatives with CCRI receptor antagonist activity
02/02/2005CN1575279A Substituted thioacetamides
02/02/2005CN1575275A Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
02/02/2005CN1572754A Method for producing organic compound by substituting halogen atoms
02/02/2005CN1187348C Preparation of 5-carboxy-2-phthalide